Use of cognitive enhancers among medical students in Lithuania

Open access

Abstract

AIMS – The purpose of this study is to analyse the use of cognitive enhancers among medical students in Lithuania, determine the reasons for usage and evaluate the contributing factors such as socio-demographic characteristics, stress levels, sleep quality and knowing somebody who has used a neuro-enhancing drug.

DESIGN – A cross-sectional survey study was performed by analysing a convenience sample of n=579 in the two universities offering medical education in Lithuania, Vilnius University and the Lithuanian University of Health Sciences. In 2014, students were asked to fill in anonymous paper questionnaires consisting of 13 items on prevalence of substance use to enhance cognitive performance, and on reasons and correlates (response rate 95%) during lecture time.

RESULTS – Of the respondents, 8.1% indicated that they had used cognitive enhancers. Among those who had used these drugs, nootropics were the most frequently mentioned (59.6%), while psychostimulants, such as modafinil, methylphenidate and amphetamine-derived drugs were mentioned less frequently (38.3%). Other substances were indicated by 23.4% of the respondents. Improvement of concentration and increased studying time were predominant purposes (55.3% and 48.9% of users, respectively). Male students reported three times higher prevalence rates than females (14.6% vs. 5.1%, p<0.05). Prevalence was also higher in students who knew someone using these substances than among those who did not know such persons (17.3% vs. 5.1%, p< 0.05). This was the most associated factor with cognitive-enhancing drug-taking behaviour. No correlation between cognitive enhancement usage and sleep quality or stress levels was found, nor between usage and belonging to a student organisation or having a job.

CONCLUSIONS – In Lithuania, 1 of 12 medical students admits to having used neuro-enhancing drugs. Our study results provide an overview of the actual situation on correlates and reasons for taking performance-enhancing substances.

Benotsch, E. G., Jeffers, A. J., Snipes, D. J., Martin, A. M., & Koester, S. (2013). The five factor model of personality and the non-medical use of prescription drugs: Associations in a young adult sample. Personality and Individual Differences, 55(7), 852–855.

Bogle, K. E., & Smith, B. H. (2009). Illicit methylphenidate use: A review of prevalence, availability, pharmacology, and consequences. Current Drug Abuse Reviews, 2(2), 157–176.

Cakic, V. (2009). Smart drugs for cognitive enhancement: Ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35(10), 611–615.

Caldwell, Jr., J. A., Caldwell, J. L., Brown, D. L., & Smith, J. K. (2004). The effects of 37 hours of continuous wakefulness on the physiological arousal, cognitive performance, self-reported mood, and simulator flight performance of F-117A pilots. Military Psychology, 16(3), 163–181.

Carroll, B. C., McLaughlin, T. J., & Blake, D. R. (2006). Patterns and knowledge of nonmedical use of stimulants among college students. Archives of Pediatrics & Adolescent Medicine, 160(5), 481–485.

Castaldi, S., Gelatti, U., Orizio, G., Hartung, U., Moreno-Londono, A. M., Nobile, M., & Schulz, P. J. (2012). Use of cognitive enhancement medication among northern Italian university students. Journal of Addiction Medicine, 6(2), 112–117.

Clegg-Kraynok, M. M., McBean, A. L., & Montgomery-Downs, H. E. (2011). Sleep quality and characteristics of college students who use prescription psychostimulants nonmedically. Sleep Medicine, 12(6), 598–602.

Coper, H., & Herrmann, W. (1988). Psychostimulants, analeptics, nootropics: An attempt to differentiate and assess drugs designed for the treatment of impaired brain functions. Pharmacopsychiatry, 21(5), 211–217.

Corazza, O., Bersani, F. S., Brunoro, R., Valeriani, G., Martinotti, G., & Schifano, F. (2014). The diffusion of performance and image-enhancing Drugs (PIEDs) on the Internet: The abuse of the cognitive enhancer piracetam. Substance Use & Misuse, 49(14), 1849–1856.

Dees, R. H. (2007). Better brains, better selves? The ethics of neuroenhancements. Kennedy Institute of Ethics Journal, 17(4), 371–395.

DeSantis, A. D., Webb, E. M., & Noar, S. M. (2008). Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. Journal of American College Health, 57(3), 315–324.

Dietz, P., Striegel, H., Franke, A. G., Lieb, K., Simon, P., & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33(1), 44–50.

Dussault, C. L., & Weyandt, L. L. (2013). An examination of prescription stimulant misuse and psychological variables among sorority and fraternity college populations. Journal of Attention Disorders, 17(2), 87–97.

Eickenhorst, P., Vitzthum, K., Klapp, B. F., Groneberg, D., & Mache, S. (2012). Neuroenhancement among German university students: Motives, expectations, and relationship with psychoactive lifestyle drugs. Journal of Psychoactive Drugs, 44(5), 418–427.

Emanuel, R. M., Frellsen, S. L., Kashima, K. J., Sanguino, S. M., Sierles, F. S., & Lazarus, C. J. (2013). Cognitive enhancement drug use among future physicians: Findings from a multi-institutional census of medical students. Journal of General Internal Medicine, 28(8), 1028–1034.

European Medicines Agency (2010). Annual report. Retrieved from: http://www.ema.europa.eu/docs/en_GB/document_library/Annual_report/2011/06/WC500108073.pdf

Finger, G., Da Silva, E. R., & Falavigna, A. (2013). Use of methylphenidate among medical students: A systematic review. Revista Da Associacao Medica Brasileira, 59(3), 285–289.

Franke, A. G., & Lieb, K. (2010). Pharmakologisches neuroenhancement und “hirndoping”: Chancen und risiken. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz, 53(8), 853–860.

Garnier-Dykstra, L. M., Pinchevsky, G. M., Caldeira, K. M., Vincent, K. B., & Arria, A. M. (n.d.). Self-reported adult attention-deficit/hyperactivity disorder symptoms among college students. Journal of American College Health, 59(2), 133–136.

Gill, M., Haerich, P., Westcott, K., Godenick, K. L., & Tucker, J. a. (2006). Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: A double-blind randomized crossover study. Academic Emergency Medicine, 13(2), 158–165.

Grigg, D. (2004). Wine, spirits and beer: World patterns of consumption. Geography, 89(2), 99–110.

Habibzadeh, A., Alizadeh, M., Malek, A., Maghbooli, L., Shoja, M. M., & Ghabili, K. (2011). Illicit methylphenidate use among Iranian medical students: Prevalence and knowledge. Drug Design, Development and Therapy, 5, 71–76.

Humayun, M. U., Rader, R. S., Pieramici, D. J., Awh, C. C., & de Juan, E. (1997). Quantitative measurement of the effects of caffeine and propranolol on surgeon hand tremor. Archives of ophthalmology, 115(3), 371–374.

Jiao, X., Velez, S., Ringstad, J., Eyma, V., Miller, D., & Bleiberg, M. (2009). Myocardial infarction associated with Adderall XR and alcohol use in a young man. Journal of the American Board of Family Medicine, 22(2), 197–201.

Judson, R., & Langdon, S. W. (2009). Illicit use of prescription stimulants among college students: Prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychology, Health & Medicine, 14(1), 97–104.

King, J. E. (2007). Standardized coefficients in logistic regression. Paper presented at the annual meeting of the Southwest Educational Research Association, San Antonio, Texas. Online document at http://www.ccitonline.org/jking/homepage/standardized_paper.doc

Kudlow, P. a., Treurnicht Naylor, K., Xie, B., & McIntyre, R. S. (2013). Cognitive enhancement in Canadian medical students. Journal of Psychoactive Drugs, 45(4), 360–365.

Low, K. G., & Gendaszek, A. E. (2002). Illicit use of psychostimulants among college students: A preliminary study. Psychology, Health & Medicine, 7(3), 283–287.

Mache, S., Eickenhorst, P., Vitzthum, K., Klapp, B. F., & Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: Frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162(11–12), 262–271.

Maier, L. J., Liechti, M. E., Herzig, F., & Schaub, M. P. (2013). To dope or not to dope: Neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS ONE, 8(11).

Mazanov, J., Dunn, M., Connor, J., & Fielding, M.-L. (2013). Substance use to enhance academic performance among Australian university students. Performance Enhancement & Health, 2(3), 110–118.

McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005). Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction, 100(1), 96–106.

McNiel, A. D., Muzzin, K. B., DeWald, J. P., McCann, A. L., Schneiderman, E. D., Scofield, J., & Campbell, P. R. (2011). The nonmedical use of prescription stimulants among dental and dental hygiene students. Journal of Dental Education, 75(3), 365–376.

Normann, C., & Berger, M. (2008). Neuroenhancement: Status quo and perspectives. European Archives of Psychiatry and Clinical Neuroscience, 258, 110–114.

OECD/European Union (2014). Alcohol consumption among adults. In Health at a Glance: Europe 2014. Paris: OECD Publishing.

Pary, R., Lewis, S., Matuschka, P., Rudzinskiy, P., Safi, M., & Lippmann, S. (2002). Attention deficit disorder in adults. Annals of Clinical Psychiatry, 14(2), 105–111.

Ragan, C. I., Bard, I., & Singh, I. (2013). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology, 64, 588–595.

Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 62(3), 187–206.

Room, R. (2002). The effects of Nordic alcohol policies: What happens to drinking and harm when alcohol controls change? Helsinki: Nordic Council for Alcohol and Drug Research.

Sandberg, A., Sinnott-Armstrong, W., & Savulescu, J. (2011). Cognitive enhancement in courts. In J. Illes & B. J. Shakakian (Eds.), The Oxford handbook of neuroethics (pp. 273–285). Oxford: Oxford University Press.

Sattler, S., Forlini, C., Racine, É., & Sauer, C. (2013). Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLoS ONE, 8(8).

Stolerman, I. P. (2010). Encyclopedia of psychopharmacology (Vol. 1). Berlin and Heidelberg: Springer Science & Business Media.

Sylvester, A. L., & Agarwala, B. (2012). Acute myocardial infarction in a teenager due to Adderall XR. Pediatric Cardiology, 33(1), 155–157.

Teter, C. J., Falone, A. E., Cranford, J. a., Boyd, C. J., & McCabe, S. E. (2010). Nonmedical use of prescription stimulants and depressed mood among college students: Frequency and routes of administration. Journal of Substance Abuse Treatment, 38(3), 292–298.

Urrego Acevedo, M., Arango Orozco, L., Blandon Montoya, L., Buelvas Soto, L., Carmona Velazquez, D. V., Castanho Castrillon, J. J., … Arango, C. (2009). Consumo de anfetaminas, para mejorar rendimiento academico, en estudiantes de la Universidad de Manizales. Archivos de Medicina, 9(1), 43–57.

Verdi, G. (2013). Academic and psychological factors in non-medical prescription stimulant use in graduate students. Open Access Dissertations. Paper 52. Retrieved from http://digitalcommons.uri.edu/oa_diss/52

Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., … Blumberg, S. J. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child and Adolescent Psychiatry, 53(1), 34–46.e2.

Voren, R. (2013). Psychiatry as a tool for coercion in post-Soviet countries. Luxembourg: Publications Office.

Warren, O. J., Leff, D. R., Athanasiou, T., Kennard, C., & Darzi, A. (2009). The neurocognitive enhancement of surgeons: An ethical perspective. Journal of Surgical Research, 152(1), 167–172.

Webb, J. R., Valasek, M. a., & North, C. S. (2013). Prevalence of stimulant use in a sample of US medical students. Annals of Clinical Psychiatry, 25(1), 27–32.

Weyandt, L. L., Janusis, G., Wilson, K. G., Verdi, G., Paquin, G., Lopes, J., … Dussault, C. (2009). Nonmedical prescription stimulant use among a sample of college students: Relationship with psychological variables. Journal of Attention Disorders, 13(3), 284–296.

White, B. P., Becker-Blease, K. A., & Grace-Bishop, K. (2006). Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. Journal of American College Health, 54(5), 261–268.

WHO Collaborating Centre for Drug Statistics Methodology (2012). Guidelines for ATC classification and DDD assignment 2013. Oslo: Norwegian Institute of Public Health.

Wulf, M.-A., Joksimovic, L., & Tress, W. (2011). Das Ringen um Sinn und Anerkennung – Eine psychodynamische Sicht auf das Phänomen des Neuroenhancement (NE). Ethik in Der Medizin, 24(1), 29–42.

Nordic Studies on Alcohol and Drugs

The Journal of Nordic Centre for Welfare and Social Issues

Journal Information


IMPACT FACTOR 2017: 0.683
5-year IMPACT FACTOR: 0.752


CiteScore 2018: 0.64

SCImago Journal Rank (SJR) 2018: 0.313
Source Normalized Impact per Paper (SNIP) 2018: 0.456



Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 139 126 10
PDF Downloads 65 62 5